• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pofut1的过表达和激活的Notch1可能与乳腺癌的不良预后相关。

Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer.

作者信息

Wan Guoxing, Tian Lin, Yu Yuandong, Li Fang, Wang Xuanbin, Li Chen, Deng Shouheng, Yu Xiongjie, Cai Xiaojun, Zuo Zhigang, Cao Fengjun

机构信息

Department of Oncology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China.

Department of Pathology, Renmin Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China.

出版信息

Biochem Biophys Res Commun. 2017 Sep 9;491(1):104-111. doi: 10.1016/j.bbrc.2017.07.053. Epub 2017 Jul 11.

DOI:10.1016/j.bbrc.2017.07.053
PMID:28709865
Abstract

PURPOSE

The present study was to evaluate the prognostic value of protein expression of Pofut1 and Notch1 signaling in breast cancer.

MATERIAL AND METHODS

Formalin-fixed paraffin-embedded 314 breast specimens including 174 infiltrating ductal carcinoma(IDC), 50 ductal carcinoma in situ(DCIS) and 90 adjacent normal tissue(ANT) were immunohistochemically examined to evaluate the protein expression of Pofut1, activated Notch1(N1IC) and Slug on specimens. Survival analysis was performed by Kaplan-Meier method and Cox's proportional-hazards model. A online database was computationally used to further explore the prognostic role of Pofut1 and Notch1 mRNA expression by Kaplan-Meier Plotter.

RESULTS

Pofut1, Slug and N1IC expression were significantly increased in IDC compared to ANT(all p < 0.05). High expression of Pofut1, Slug and N1IC were associated with tumor aggressiveness including lymph node metastasis (LNM: p = 0.005 for Pofut1, p < 0.001 for N1IC, p = 0.017 for Slug), advanced stage(p = 0.039 for Pofut1, p = 0.025 for N1IC) and higher histological grade(p = 0.001 for N1IC). Additionally, high expression of Pofut1 was found to be significantly associated with high expressions of N1IC and Slug in IDC(r = 0.244, p = 0.001; r = 0.374, p < 0.001, respectively), similar correlation was also observed between high N1IC and Slug expression(r = 0.496, p < 0.001). Moreover, Kaplan-Meier and Cox's regression analysis indicated the significant prognostic value of elevated Pofut1, N1IC, Slug expressions, positive LNM and advanced tumor stage for the prediction of a shorter disease-free survival (DFS) and overall survival(OS). The web-based analysis also suggested a significant association of high Pofut1 and Notch1 mRNA expression with worse survival outcome.

CONCLUSION

Our findings suggested that overexpression of Pofut1 and activated Notch1 signaling may be associated with a poor prognosis in breast cancer.

摘要

目的

本研究旨在评估Pofut1蛋白表达及Notch1信号通路在乳腺癌中的预后价值。

材料与方法

采用免疫组织化学方法检测314例福尔马林固定石蜡包埋的乳腺标本,其中包括174例浸润性导管癌(IDC)、50例原位导管癌(DCIS)和90例癌旁正常组织(ANT),以评估标本中Pofut1、活化的Notch1(N1IC)和Slug的蛋白表达。采用Kaplan-Meier法和Cox比例风险模型进行生存分析。通过在线数据库,利用Kaplan-Meier Plotter进一步探究Pofut1和Notch1 mRNA表达的预后作用。

结果

与ANT相比,IDC中Pofut1、Slug和N1IC的表达显著增加(均p < 0.05)。Pofut1、Slug和N1IC的高表达与肿瘤侵袭性相关,包括淋巴结转移(LNM:Pofut1为p = 0.005,N1IC为p < 0.001,Slug为p = 0.017)、晚期(Pofut1为p = 0.039,N1IC为p = 0.025)和更高的组织学分级(N1IC为p = 0.001)。此外,在IDC中发现Pofut1的高表达与N1IC和Slug的高表达显著相关(r = 0.244,p = 0.001;r = 0.374,p < 0.001),N1IC和Slug的高表达之间也观察到类似的相关性(r = 0.496,p < 0.001)。此外,Kaplan-Meier和Cox回归分析表明,Pofut1、N1IC、Slug表达升高、阳性LNM和晚期肿瘤分期对预测较短的无病生存期(DFS)和总生存期(OS)具有显著的预后价值。基于网络的分析还表明,Pofut1和Notch1 mRNA高表达与较差的生存结果显著相关。

结论

我们的研究结果表明,Pofut1的过表达和Notch1信号通路的激活可能与乳腺癌预后不良有关。

相似文献

1
Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer.Pofut1的过表达和激活的Notch1可能与乳腺癌的不良预后相关。
Biochem Biophys Res Commun. 2017 Sep 9;491(1):104-111. doi: 10.1016/j.bbrc.2017.07.053. Epub 2017 Jul 11.
2
Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.SIRT1与Notch1信号通路在乳腺癌中的相关性及预后价值
J Exp Clin Cancer Res. 2014 Nov 25;33(1):97. doi: 10.1186/s13046-014-0097-2.
3
Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.Notch1-Snail/Slug-上皮-间质转化轴在浸润性导管癌淋巴结转移中的意义
Kaohsiung J Med Sci. 2015 Feb;31(2):70-6. doi: 10.1016/j.kjms.2014.11.008. Epub 2014 Dec 16.
4
[Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].[Notch1甲基化在乳腺癌及乳腺导管内增生性病变中的检测及其临床意义]
Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):324-9.
5
[Notch1 mRNA and protein expression in human breast cancer and normal mammary gland tissues].[人乳腺癌和正常乳腺组织中Notch1 mRNA及蛋白表达]
Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):806-9.
6
Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.Runx2表达作为浸润性导管癌潜在的预后标志物
Pathol Oncol Res. 2016 Jul;22(3):461-70. doi: 10.1007/s12253-015-0018-5. Epub 2015 Nov 23.
7
LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.亮氨酸拉链反式作用因子1(LETM1)过表达与乳腺癌的临床特征及生存结果相关。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12893-900. eCollection 2015.
8
Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.Tiam1在乳腺浸润性导管癌中过表达的临床病理意义
BMC Cancer. 2016 Aug 25;16(1):681. doi: 10.1186/s12885-016-2724-0.
9
NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.NEDD4 的表达与乳腺癌的进展相关,并且可以预测不良预后。
Breast Cancer Res. 2019 Dec 19;21(1):148. doi: 10.1186/s13058-019-1236-7.
10
Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.MAGE-A9的过表达预示着乳腺癌的不良预后。
Exp Mol Pathol. 2014 Dec;97(3):579-84. doi: 10.1016/j.yexmp.2014.11.001. Epub 2014 Nov 5.

引用本文的文献

1
POFUT1 as a cancer biomarker: insights into its oncogenic mechanisms and clinical relevance.POFUT1作为一种癌症生物标志物:对其致癌机制和临床相关性的见解。
J Mol Med (Berl). 2025 Aug 7. doi: 10.1007/s00109-025-02578-1.
2
CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects.CRISPR/Cas9技术在肿瘤研究及药物研发中的应用进展与未来前景
Front Pharmacol. 2025 Jul 8;16:1552741. doi: 10.3389/fphar.2025.1552741. eCollection 2025.
3
Potential role of POFUT1 as a prognostic predictor in low-grade gliomas: Immune microenvironment insights from a pan-cancer analysis.
POFUT1作为低级别胶质瘤预后预测指标的潜在作用:来自泛癌分析的免疫微环境见解
Heliyon. 2024 Feb 27;10(5):e27004. doi: 10.1016/j.heliyon.2024.e27004. eCollection 2024 Mar 15.
4
Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research.人类多能干细胞中的 20q11.21 增益:癌症研究的新视角。
Stem Cell Reports. 2024 Jan 9;19(1):11-27. doi: 10.1016/j.stemcr.2023.11.013. Epub 2023 Dec 28.
5
Preliminary study on the mechanism of POFUT1 in colorectal cancer.结直肠癌中 POFUT1 作用机制的初步研究。
Med Oncol. 2023 Jul 11;40(8):235. doi: 10.1007/s12032-023-02102-w.
6
Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis.骨肉瘤生长中的信号通路和 microRNAs 以及间充质干细胞在致癌中的双重作用。
Int J Mol Sci. 2023 May 19;24(10):8993. doi: 10.3390/ijms24108993.
7
Identifying distinctive tissue and fecal microbial signatures and the tumor-promoting effects of deoxycholic acid on breast cancer.鉴定有区别的组织和粪便微生物特征以及脱氧胆酸对乳腺癌的促瘤作用。
Front Cell Infect Microbiol. 2022 Dec 13;12:1029905. doi: 10.3389/fcimb.2022.1029905. eCollection 2022.
8
Prognostic and clinicopathological value of Slug protein expression in breast cancer: a systematic review and meta-analysis.Slug 蛋白表达在乳腺癌中的预后和临床病理价值:系统评价和荟萃分析。
World J Surg Oncol. 2022 Nov 14;20(1):361. doi: 10.1186/s12957-022-02825-6.
9
Low expression of cytosolic NOTCH1 predicts poor prognosis of breast cancer patients.细胞质中NOTCH1低表达预示着乳腺癌患者的预后不良。
Am J Cancer Res. 2022 May 15;12(5):2084-2101. eCollection 2022.
10
Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models.癌症中的糖基转移酶:患者队列生存的预后生物标志物及对实验模型中恶性肿瘤的影响
Cancers (Basel). 2022 Apr 24;14(9):2128. doi: 10.3390/cancers14092128.